Quick Answer
Corvus Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 74.70 million shares for the year ending 2025.
- Corvus Pharmaceuticals, Inc. showed an increase of +10.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Corvus Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Corvus Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 5,117.6%.
- Historical annual values: Fiscal year 2025: 74.70 million shares | Fiscal year 2024: 67.90 million shares | Fiscal year 2023: 49.04 million shares | Fiscal year 2022: 46.55 million shares | Fiscal year 2021: 46.55 million shares | Fiscal year 2020: 28.37 million shares | Fiscal year 2019: 27.95 million shares | Fiscal year 2018: 29.32 million shares | Fiscal year 2017: 21.04 million shares | Fiscal year 2016: 20.92 million shares | Fiscal year 2015: 1.43 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: